May Saif
Psychiatric/Mental Health · Smithtown, NYNPI 1841834595
Payments from drug & device makers
Across 139 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$589
- Takeda Pharmaceuticals U.S.A., Inc.$553
- Otsuka America Pharmaceutical, Inc.$236
- Lundbeck LLC$228
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$220
- Neurocrine Biosciences, Inc.$194
- plus $516 from 9 others
What the payments were for
- Food & beverage$2,536100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $589 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $553 |
| Otsuka America Pharmaceutical, Inc. | 12 | $236 |
| Lundbeck LLC | 12 | $228 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $220 |
| Neurocrine Biosciences, Inc. | 8 | $194 |
| Vanda Pharmaceuticals Inc. | 7 | $127 |
| Teva Pharmaceuticals USA, Inc. | 6 | $112 |
| Bausch Health US, LLC | 5 | $103 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Almatica Pharma LLC | 1 | $14 |
How this compares
$2,536 in reported general payments places this provider in the 80th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 38 | $35,694 |
| BelsomraSuvorexant | 20 | $8,849 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 124 | $4,610 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 123 | $3,190 |
| Bupropion XlBupropion Hcl | 143 | $2,451 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 31 | $1,738 |
| Alprazolam | 179 | $1,615 |
| Quetiapine Fumarate | 79 | $1,549 |
| Clonazepam | 65 | $915 |
| Lamotrigine | 83 | $744 |
| Duloxetine Hcl | 43 | $581 |
| Escitalopram Oxalate | 55 | $520 |
| Prazosin Hcl | 20 | $488 |
| Risperidone | 24 | $371 |
| Alprazolam ErAlprazolam | 13 | $350 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $553 | $35,69438 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $24631 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Smithtown
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Mary OlsonNew York$142K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.